2022年神经肌肉病理学最新进展:肌病更新和基因治疗。
IF 1.7
Q3 PATHOLOGY
引用次数: 0
摘要
这份关于肌肉和神经疾病诊断和治疗新变化的汇编摘自欧洲神经肌肉中心国际研讨会、FDA.gov和clinicaltrials.gov的最新出版物。本文章由计算机程序翻译，如有差异，请以英文原文为准。
What's new in neuromuscular pathology 2022: myopathy updates and gene therapies.
This compilation of new changes in the diagnosis and treatment of muscle and nerve disease is extracted from the latest publications from the European Neuromuscular Centre International workshops, FDA.gov and clinicaltrials.gov.
求助全文
通过发布文献求助，成功后即可免费获取论文全文。
去求助
来源期刊
CiteScore
5.00
自引率
4.20%
发文量
45
审稿时长
14 weeks
期刊介绍：
The Journal of Pathology and Translational Medicine is an open venue for the rapid publication of major achievements in various fields of pathology, cytopathology, and biomedical and translational research. The Journal aims to share new insights into the molecular and cellular mechanisms of human diseases and to report major advances in both experimental and clinical medicine, with a particular emphasis on translational research. The investigations of human cells and tissues using high-dimensional biology techniques such as genomics and proteomics will be given a high priority. Articles on stem cell biology are also welcome. The categories of manuscript include original articles, review and perspective articles, case studies, brief case reports, and letters to the editor.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
